vMCO-I

N/A

Report date: 2025/10/31 20:01:33

Base Information

Drug NamevMCO-I
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2 vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinal DiseasesRetinitis PigmentosaRetinal Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNanoscope Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanoscope Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsRetinal DiseasesRetinitis PigmentosaRetinal Degeneration

Other Information

ATC CodeN/A
Related LinksN/A